DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
Upcoming Supplemental Issue and Call for Abstracts
On behalf of the sponsor, CVSHealth, the Journal of Health Care for the Poor and Underserved issues a Call for Abstracts on the topic of Public-Private Partnerships and Health Equity. The scope of the supplemental issue is the significance and value of public-private partnerships (including but not limited to corporate, non-profit, local, state or national government, or academic) to advance health equity and/or address the social determinants of health; additionally, the issue will identify potential directions for future work in this area.
Abstracts should be blinded and should be no longer than 350 words long. The authors should include a list of key words (which will not count toward the word count of the abstract). Please submit abstracts to [email protected] no later than midnight, February 1, 2022.
This event has ended.
+myBinderRelated Content
-
education & researchPodcast: How New Gene Therapies for SCD May Impact Women’s FertilityAs we closed 2023, the Food and Drug Ad...
-
education & researchNewborn Screening Guide for ParentsMost babies born in the United States ar...
-
people & placesEdith Peterson Mitchell, MDEdith Peterson Mitchell, MD, is board ce...
-
news & eventsOrphan Drug Designation Granted for CSL Behring’s Investigational Plasma-Derived Hemopexin Therapy for Sickle ...Global biotherapeutics leader CSL Behrin...
-
news & eventsEmmaus, a leader in sickle cell disease treatment, signs agreement with Cardinal Health to solidify distribution net...Emmaus Life Sciences, Inc. announces...
-
news & eventsFDA Advisory Committee Recommends Approval of Endari™ from Emmaus Life Sciences for the Treatment of Sickle Cell D...Emmaus Life Sciences Inc. announced toda...
-
people & placesAllan F. Platt, MMSc, PA-C, DFAAPAAllan Platt has served as co-founder and...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.